Accelerating Tec-Dara Multiple Myeloma Therapy ...

By HEOR Staff Writer

December 16, 2025

Accelerating Review for Transformative Multiple Myeloma Therapy The U.S. Food and Drug Administration (
CHMP Meeting Highlights: December 2025 Advances in New Medicines Approvals
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
Provisional Agreement on EU Pharmaceutical Reform: Boosting Innovation and Co...
Innovations in Haematology Cell Therapy at ASH 2025
NICE Endorses Obecabtagene Autoleucel Therapy for Adult Relapsed B-Cell Leuka...
Accelerating Access to Latin America Innovative Therapies Through Collaborati...
Addressing AI Polyp Detection Gaps: A Roadmap for Evidence Generation and NHS...
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Promising Advances in TNBC Treatment: Sacituzumab Govitecan in First-Line The...
Interchangeable Biosimilar Approval: FDA Greenlights Poherdy as First to Perjeta
Navigating Targeted Therapy Access: Innovations and Challenges in High-Cost T...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access